BioNTech (BNTX)
(Delayed Data from NSDQ)
$96.31 USD
-1.84 (-1.87%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $96.55 +0.24 (0.25%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, BioNTech SE Sponsored ADR has a market cap of $23.60B, which represents its share price of $98.15 multiplied by its outstanding shares number of 240.40M. As a large-cap company, BNTX's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BNTX 96.31 -1.84(-1.87%)
Will BNTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTX
MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?
Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold?
SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study
Other News for BNTX
CDC vaccines panel head Kulldorff challenges former directors to debate
New York issues its own COVID-19 vaccine guidance
Is BNTX coiling for a breakout? Calm After Storm shows up after sliding 1.12%
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
Former CDC Director Monarez says RFK Jr. fired her for not following two directives